Literature DB >> 7490723

New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii.

S F Queener1.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7490723     DOI： 10.1021/jm00024a001

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  14 in total

1.  In vitro selection and in vivo efficacy of piperazine- and alkanediamide-linked bisbenzamidines against Pneumocystis pneumonia in mice.

Authors:  Melanie T Cushion; Peter D Walzer; Alan Ashbaugh; Sandra Rebholz; Ronald Brubaker; Jean Jacques Vanden Eynde; Annie Mayence; Tien L Huang
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

2.  Activities and conformational fitting of 1,4-naphthoquinone derivatives and other cyclic 1,4-diones tested in vitro against Pneumocystis carinii.

Authors:  M D Ball; M S Bartlett; M Shaw; J W Smith; M Nasr; S R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

3.  Isolation of rat dihydrofolate reductase gene and characterization of recombinant enzyme.

Authors:  Y Wang; J A Bruenn; S F Queener; V Cody
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

4.  Highly active anti-Pneumocystis carinii compounds in a library of novel piperazine-linked bisbenzamidines and related compounds.

Authors:  Melanie T Cushion; Peter D Walzer; Margaret S Collins; Sandra Rebholz; Jean Jacques Vanden Eynde; Annie Mayence; Tien L Huang
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

5.  Pentamidine inhibits mitochondrial intron splicing and translation in Saccharomyces cerevisiae.

Authors:  Y Zhang; A Bell; P S Perlman; M J Leibowitz
Journal:  RNA       Date:  2000-07       Impact factor: 4.942

6.  IMP dehydrogenase from Pneumocystis carinii as a potential drug target.

Authors:  M J O'Gara; C H Lee; G A Weinberg; J M Nott; S F Queener
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

7.  Pentamidine analogs as inhibitors of [(3)H]MK-801 and [(3)H]ifenprodil binding to rat brain NMDA receptors.

Authors:  Michael L Berger; Dorota Maciejewska; Jean Jacques Vanden Eynde; Madhusoodanan Mottamal; Jerzy Żabiński; Paweł Kaźmierczak; Mateusz Rezler; Ivana Jarak; Ivo Piantanida; Grace Karminski-Zamola; Annie Mayence; Patrick Rebernik; Arvind Kumar; Mohamed A Ismail; David W Boykin; Tien L Huang
Journal:  Bioorg Med Chem       Date:  2015-06-14       Impact factor: 3.641

8.  Pentamidine inhibition of group I intron splicing in Candida albicans correlates with growth inhibition.

Authors:  K E Miletti; M J Leibowitz
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

9.  The inhibitory effect of pentamidine on the production of chemotactic cytokines by in vitro stimulated human blood cells.

Authors:  J Van Wauwe; F Aerts; H Van Genechten; H Blockx; W Deleersnijder; H Walter
Journal:  Inflamm Res       Date:  1996-07       Impact factor: 4.575

10.  Recombinant bovine dihydrofolate reductase produced by mutagenesis and nested PCR of murine dihydrofolate reductase cDNA.

Authors:  Vivian Cody; Qilong Mao; Sherry F Queener
Journal:  Protein Expr Purif       Date:  2008-07-17       Impact factor: 1.650
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.